Untersuchungen zur Assoziation von Polymorphismen in regulatorischen Elementen der Lipoproteinlipase und des Apolipoprotein E mit KHK und Triglyzerid-Stoffwechsel

Durch Atherosklerose bedingte Kardiovaskuläre Erkrankungen sind die Haupttodesursache in der westlichen Welt. Neben der familiären Disposition, dem Geschlecht und dem Lebensalter gibt es zahlreiche beeinflussbare Risikofaktoren für diese Erkrankungen. Zusätzlich zum Nikotin-Konsum, der arteriellen H...

Full description

Saved in:
Bibliographic Details
Main Author: Schell, Johanna Kristina
Contributors: Schäfer, Jürgen (Prof.) (Thesis advisor)
Format: Dissertation
Language:German
Published: Philipps-Universität Marburg 2011
Innere Medizin
Subjects:
SNP
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

1. Merkel, M., Eckel, R. H., Goldberg, I. J. (2002a) Lipoprotein lipase: genetics, lipid uptake, and regulation. J.Lipid Res. 43, 1997-2006


2. Hall, S., Talmud, P. J., Cook, D. G., Wicks, P. D., Rothwell, M. J., Strazzullo, P., Sagnella, G. A., Cappuccio, F. P. (2000) Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study. Genet.Epidemiol. 18, 203-216


3. Hall, S., Chu, G., Miller, G., Cruickshank, K., Cooper, J. A., Humphries, S. E., Tal- mud, P. J. (1997) A common mutation in the lipoprotein lipase gene promoter, - 93T/G, is associated with lower plasma triglyceride levels and increased promo- ter activity in vitro. Arterioscler.Thromb.Vasc.Biol. 17, 1969-1976


4. Schaefer, J. R., Simon, B., Soufi, M., Sattler, A., Noll, B., Herzum, M., Maisch, B. (2000) Strategies to optimize CAD prevention in modern cardiology. The "Mar- burg CAD Prevention Project". Herz 25, 113-116


5. Hense, H. W., Schulte, H., Lowel, H., Assmann, G., Keil, U. (2003) Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur.Heart J. 24, 937-945


6. Shih, S. J., Allan, C., Grehan, S., Tse, E., Moran, C., Taylor, J. M. (2000) Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J.Biol.Chem. 275, 31567-31572


7. Myers, R. M., Fischer, S. G., Lerman, L. S., Maniatis, T. (1985) Nearly all single ba- se substitutions in DNA fragments joined to a GC-clamp can be detected by de- naturing gradient gel electrophoresis. Nucleic Acids Res. 13, 3131-3145


8. Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., Ockene, I. S., Pearson, T. A., Reed, J., Washington, R., Smith, S. C., Jr. (1998) Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. Ameri- can Heart Association. Circulation 97, 1876-1887


9. Grundy, S. M., Bazzarre, T., Cleeman, J., D'Agostino, R. B., Sr., Hill, M., Houston- Miller, N., Kannel, W. B., Krauss, R., Krumholz, H. M., Lauer, R. M., Ockene, I. S., Pasternak, R. C., Pearson, T., Ridker, P. M., Wood, D. (2000) Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation 101, E3-E11


10. Maeno, Y., Kashiwagi, A., Nishio, Y., Takahara, N., Kikkawa, R. (2000) IDL can sti- mulate atherogenic gene expression in cultured human vascular endothelial cells. Diabetes Res.Clin.Pract. 48, 127-138


11. Schoonjans, K., Gelman, L., Haby, C., Briggs, M., Auwerx, J. (2000) Induction of LPL gene expression by sterols is mediated by a sterol regulatory element and is independent of the presence of multiple E boxes. J.Mol.Biol. 304, 323-334


12. Kirchgessner, T. G., Chuat, J. C., Heinzmann, C., Etienne, J., Guilhot, S., Svenson, K., Ameis, D., Pilon, C., d'Auriol, L., Andalibi, A., . (1989a) Organization of the human lipoprotein lipase gene and evolution of the lipase gene family. Proc.Natl.Acad.Sci.U.S.A 86, 9647-9651


13. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol.Cell 2, 275-281


14. Mailly, F., Tugrul, Y., Reymer, P. W., Bruin, T., Seed, M., Groenemeyer, B. F., Asp- lund Carlson, A., Vallance, D., Winder, A. F., Miller, G. J., et al (1995) A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arteriosc- ler.Thromb.Vasc.Biol. 15, 468-478


15. Nagai, M., Yoshida, A., Sato, N. (1998) Additive effects of bovine serum albumin, dithiothreitol, and glycerol on PCR. Biochem.Mol.Biol.Int. 44, 157-163


16. Simonet, W. S., Bucay, N., Lauer, S. J., Taylor, J. M. (1993) A far-downstream he- patocyte-specific control region directs expression of the linked human apoli- poprotein E and C-I genes in transgenic mice. J.Biol.Chem. 268, 8221-8229


17. Mahley, R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630


18. Mahley, R. W. und Rall, S. C., Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu.Rev.Genomics Hum.Genet. 1:507-37., 507-537


19. Zechner, R., Moser, R., Newman, T. C., Fried, S. K., Breslow, J. L. (1991) Apoli- poprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J.Biol.Chem. 266, 10583-10588


20. Zilversmit, D. B. (1973) A proposal linking atherogenesis to the interaction of endo- thelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ.Res. 33, 633-638


21. Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Naka- gawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., Sugiyama, S., Nakano, T., Nakajima, K., Yasue, H. (1998) Association of remnant lipoprotein levels with im- pairment of endothelium-dependent vasomotor function in human coronary arte- ries. Circulation 97, 2519-2526


22. Sheffield, V. C., Cox, D. R., Lerman, L. S., Myers, R. M. (1989) Attachment of a 40- base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc.Natl.Acad.Sci.U.S.A 86, 232-236


23. Libby, P. (2000) Changing concepts of atherogenesis. J.Intern.Med. 247, 349-358


24. Kawasaki, S., Taniguchi, T., Fujioka, Y., Takahashi, A., Takahashi, T., Domoto, K., Taguchi, M., Ishikawa, Y., Yokoyama, M. (2000) Chylomicron remnant induces apoptosis in vascular endothelial cells. Ann.N.Y.Acad.Sci. 902, 336-341


25. Okumura, T., Fujioka, Y., Morimoto, S., Masai, M., Sakoda, T., Tsujino, T., Kashi- wamura, S., Okamura, H., Ohyanagi, M. (2006) Chylomicron remnants stimulate release of interleukin-1beta by THP-1 cells. J.Atheroscler.Thromb. 13, 38-45


26. Kamemura, K., Fujioka, Y., Takaishi, H., Takahashi, A., Taniguchi, T., Ishikawa, Y., Yokoyama, M. (2006) Chylomicron remnants upregulate CD40 expression via the ERK pathway and a redox-sensitive mechanism in THP-1 cells. Atherosclerosis 187, 257-264


27. Rios, D. L., Vargas, A. F., Ewald, G. M., Torres, M. R., Zago, A. J., Callegari- Jacques, S. M., Hutz, M. H. (2003) Common variants in the lipoprotein lipase ge- ne in Brazil: association with lipids and angiographically assessed coronary athe- rosclerosis. Clin.Chem.Lab Med. 41, 1351-1356


28. Myers, R. M., Maniatis, T., Lerman, L. S. (1987) Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol. 155, 501-527


29. Murdoch, S. J. und Breckenridge, W. C. (1996) Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL. Bio- chim.Biophys.Acta 1303, 222-232


30. Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the IN- TERHEART study): case-control study. Lancet 364, 937-952


31. Klouche, M., Rose-John, S., Schmiedt, W., Bhakdi, S. (2000) Enzymatically degra- ded, nonoxidized LDL induces human vascular smooth muscle cell activation, fo- am cell transformation, and proliferation. Circulation 101, 1799-1805


32. Hokanson, J. E. (1999) Functional variants in the lipoprotein lipase gene and risk cardiovascular disease. Curr.Opin.Lipidol. 10, 393-399


33. Weisgraber, K. H., Rall, S. C., Jr., Mahley, R. W. (1981) Human E apoprotein hete- rogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo- E isoforms. J.Biol.Chem. 256, 9077-9083


34. Sparkes, R. S., Zollman, S., Klisak, I., Kirchgessner, T. G., Komaromy, M. C., Mo- handas, T., Schotz, M. C., Lusis, A. J. (1987) Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1, 138-144


35. Wion, K. L., Kirchgessner, T. G., Lusis, A. J., Schotz, M. C., Lawn, R. M. (1987) Human lipoprotein lipase complementary DNA sequence. Science 235, 1638- 1641


36. Merkel, M., Heeren, J., Dudeck, W., Rinninger, F., Radner, H., Breslow, J. L., Gold- berg, I. J., Zechner, R., Greten, H. (2002b) Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake. J.Biol.Chem. 277, 7405-7411


37. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874


38. Libby, P., Ridker, P. M., Hansson, G. K. (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J.Am.Coll.Cardiol. 54, 2129-2138


39. Murdoch, S. J. und Breckenridge, W. C. (1995) Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Atherosclerosis 118, 193-212


40. Nakshatri, H., Nakshatri, P., Currie, R. A. (1995) Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter. J.Biol.Chem. 270, 19613-19623


41. Kastelein, J. J., Jukema, J. W., Zwinderman, A. H., Clee, S., van Boven, A. J., Jan- sen, H., Rabelink, T. J., Peters, R. J., Lie, K. I., Liu, G., Bruschke, A. V., Hayden, M. R. (2000) Lipoprotein lipase activity is associated with severity of angina pec- toris. REGRESS Study Group. Circulation 102, 1629-1633


42. M., Strickland, D. K., Chappell, D. A. (1996) Lipoprotein lipase binds to low densi- ty lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. J.Biol.Chem. 271, 17073-17080


43. Preiss-Landl, K., Zimmermann, R., Hammerle, G., Zechner, R. (2002) Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr.Opin.Lipidol. 13, 471-481


44. Hessler, J. R., Morel, D. W., Lewis, L. J., Chisolm, G. M. (1983) Lipoprotein oxidati- on and lipoprotein-induced cytotoxicity. Arteriosclerosis 3, 215-222


45. Tacken, P. J., Hofker, M. H., Havekes, L. M., Van Dijk, K. W. (2001) Living up to a name: the role of the VLDL receptor in lipid metabolism. Curr.Opin.Lipidol. 12, 275-279


46. Scott, J., Knott, T. J., Shaw, D. J., Brook, J. D. (1985) Localization of genes enco- ding apolipoproteins CI, CII, and E to the p13----cen region of human chromoso- me 19. Hum.Genet. 71, 144-146


47. M. (1993) Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipopro- tein lipase. J.Biol.Chem. 268, 9369-9375


48. Talmud, P. J., Hall, S., Holleran, S., Ramakrishnan, R., Ginsberg, H. N., Humphries, S. E. (1998) LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. J.Lipid Res. 39, 1189-1196


49. Libby, P. (2009) Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis. J.Lipid Res. 50 Suppl, S352-S357


50. Simonet, W. S., Bucay, N., Pitas, R. E., Lauer, S. J., Taylor, J. M. (1991) Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J.Biol.Chem. 266, 8651-8654


51. Haley, K. J., Lilly, C. M., Yang, J. H., Feng, Y., Kennedy, S. P., Turi, T. G., Thomp- son, J. F., Sukhova, G. H., Libby, P., Lee, R. T. (2000) Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102, 2185-2189


52. Mahley, R. W., Huang, Y., Rall, S. C., Jr. (1999) Pathogenesis of type III hyperli- poproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.


53. Sun, Y., Hegamyer, G., Colburn, N. H. (1993) PCR-direct sequencing of a GC-rich region by inclusion of 10% DMSO: application to mouse c-jun. Biotechniques 15, 372-374


54. Utermann, G., Hees, M., Steinmetz, A. (1977) Polymorphism of apolipoprotein E and occurence of dysbetalipoproteinaemia in man. Nature 269, 604-607


55. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., Erlich, H. A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491


56. Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E., Gijbels, M. J., Van Dijk, K. W., Havekes, L. M., Jong, M. C. (2001) Protection from obesity in mice lacking the VLDL receptor. Arterioscler.Thromb.Vasc.Biol. 21, 1488-1493


57. Schaefer, J. R. (1998) Präventive Kardiologie. Prophylaxe der koronaren Herz- krankheit. (Schattauer Verlag, Stuttgart --New York)


58. Yang, W. S., Nevin, D. N., Iwasaki, L., Peng, R., Brown, B. G., Brunzell, J. D., Deeb, S. S. (1996) Regulatory mutations in the human lipoprotein lipase gene in pati- ents with familial combined hyperlipidemia and coronary artery disease. J.Lipid Res. 37, 2627-2637


59. Kawakami, A., Tanaka, A., Chiba, T., Nakajima, K., Shimokado, K., Yoshida, M. (2003) Remnant lipoprotein-induced smooth muscle cell proliferation involves e- pidermal growth factor receptor transactivation. Circulation 108, 2679-2688


60. Menotti, A., Scanga, M., Morisi, G. (1994) Serum triglycerides in the prediction of coronary artery disease (an Italian experience). Am.J.Cardiol. 73, 29-32


61. Sagoo, G. S., Tatt, I., Salanti, G., Butterworth, A. S., Sarwar, N., van Maarle, M., Jukema, J. W., Wiman, B., Kastelein, J. J., Bennet, A. M., De Faire, U., Danesh, J., Higgins, J. P. (2008) Seven lipoprotein lipase gene polymorphisms, lipid frac- tions, and coronary disease: a HuGE association review and meta-analysis.


62. Yang, W. S. und Deeb, S. S. (1998) Sp1 and Sp3 transactivate the human lipopro- tein lipase gene promoter through binding to a CT element: synergy with the ste- rol regulatory element binding protein and reduced transactivation of a naturally occurring promoter variant. J.Lipid Res. 39, 2054-2064


63. Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., Erlich, H. (1986) Specific en- zymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb.Symp.Quant.Biol. 51 Pt 1, 263-273


64. Mullis, K. B. und Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a poly- merase-catalyzed chain reaction. Methods Enzymol. 155, 335-350


65. Krieger, M. und Herz, J. (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu.Rev.Biochem. 63, 601-637


66. Osborne, J. C., Jr., Bengtsson-Olivecrona, G., Lee, N. S., Olivecrona, T. (1985) Studies on inactivation of lipoprotein lipase: role of the dimer to monomer disso- ciation. Biochemistry 24, 5606-5611


67. W., Gagne, S. E., Jansen, H., Seidell, J. C., Kromhout, D., Jukema, J. W., Bruschke, A. V., Boerwinkle, E., Hayden, M. R. (1998) The Asn9 variant of li- poprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. Clin.Genet. 53, 27-33


68. Williams, S. E., Inoue, I., Tran, H., Fry, G. L., Pladet, M. W., Iverius, P. H., Lalouel, J. M., Chappell, D. A., Strickland, D. K. (1994) The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related prote- in/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. J.Biol.Chem. 269, 8653-8658


69. Ross, R. (1986) The pathogenesis of atherosclerosis--an update. N.Engl.J.Med. 314, 488-500


70. Takahashi, S., Sakai, J., Fujino, T., Hattori, H., Zenimaru, Y., Suzuki, J., Miyamori, I., Yamamoto, T. T. (2004) The very low-density lipoprotein (VLDL) receptor: cha- racterization and functions as a peripheral lipoprotein receptor.


71. World Health Organization (2004) The World Health report 2004 annex Table 2. Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2003. Geneva: World Health Organization Yamamoto, T., Takahashi, S., Sakai, J., Kawarabayasi, Y. (1993) The very low den- sity lipoprotein receptor: A second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells. Trends Cardiovasc.Med. 3, 144-148


72. Zannis, V. I., Kan, H. Y., Kritis, A., Zanni, E., Kardassis, D. (2001) Transcriptional regulation of the human apolipoprotein genes. Front Biosci. 6, D456-D504


73. Jeppesen, J., Hein, H. O., Suadicani, P., Gyntelberg, F. (1998) Triglyceride con- centration and ischemic heart disease: an eight-year follow-up in the Copenha- gen Male Study. Circulation 97, 1029-1036


74. Rapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., Kane, J. P. (1994) Triglyce- ride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immuno- sorption from human atherosclerotic plaque. Arterioscler.Thromb. 14, 1767-1774


75. Hufnagel, B., Dworak, M., Soufi, M., Mester, Z., Zhu, Y., Schaefer, J. R., Klumpp, S., Krieglstein, J. (2005) Unsaturated fatty acids isolated from human lipoproteins ac- tivate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells. Atherosclerosis 180, 245-254


76. Niemeier, A., Gafvels, M., Heeren, J., Meyer, N., Angelin, B., Beisiegel, U. (1996) VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J.Lipid Res. 37, 1733-1742


77. Kostner, G. M., Scharnagl, H., Kostner K., Maerz, W. (2006). Zusammensetzung und Stoffwechsel der Lipoproteine In Handbuch der Fettstoffwechselstörungen von Schwandt, P., (Schattauer Verlag, pp. 2:65


78. Radha, V., Vimaleswaran, K. S., Ayyappa, K. A., Mohan, V. (2007) Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an A- sian Indian population. Int.J.Obes.(Lond) 31, 913-918


79. Kirchgessner, T. G., LeBoeuf, R. C., Langner, C. A., Zollman, S., Chang, C. H., Tay- lor, B. A., Schotz, M. C., Gordon, J. I., Lusis, A. J. (1989b) Genetic and develop- mental regulation of the lipoprotein lipase gene: loci both distal and proximal to the lipoprotein lipase structural gene control enzyme expression. J.Biol.Chem. 264, 1473-1482


80. Yang, W. S., Nevin, D. N., Peng, R., Brunzell, J. D., Deeb, S. S. (1995) A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial com- bined hyperlipidemia and low LPL activity. Proc.Natl.Acad.Sci.U.S.A. 92, 4462- 4466


81. Laffitte, B. A., Repa, J. J., Joseph, S. B., Wilpitz, D. C., Kast, H. R., Mangelsdorf, D. J., Tontonoz, P. (2001) LXRs control lipid-inducible expression of the apolipopro- tein E gene in macrophages and adipocytes. Proc.Natl.Acad.Sci.U.S.A 98, 507- 512


82. Henke, W., Herdel, K., Jung, K., Schnorr, D., Loening, S. A. (1997) Betaine impro- ves the PCR amplification of GC-rich DNA sequences. Nucleic Acids Res. 25, 3957-3958


83. Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropo- metric measures in Hispanics of Caribbean origin. Obesity.(Silver.Spring) 18, 327-332


84. Kannel, W. B. und Vasan, R. S. (2009) Triglycerides as vascular risk factors: new epidemiologic insights. Curr.Opin.Cardiol. 24, 345-350


85. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., Steinberg, D. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.


86. Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K., Libby, P., Luster, A. D. (1999) Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J.Clin.Invest 104, 1041-1050


87. Saxena, U., Klein, M. G., Vanni, T. M., Goldberg, I. J. (1992) Lipoprotein lipase inc- reases low density lipoprotein retention by subendothelial cell matrix. J.Clin.Invest 89, 373-380


88. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., Auwerx, J. (1996) PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipopro- tein lipase gene. EMBO J. 15, 5336-5348


89. Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J., Yamamoto, T. (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like prote- in with distinct ligand specificity. Proc.Natl.Acad.Sci.U.S.A. 89, 9252-9256


90. Yla-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Goldberg, I. J., Steinberg, D., Witz- tum, J. L. (1991) Macrophages and smooth muscle cells express lipoprotein lipa- se in human and rabbit atherosclerotic lesions. Proc.Natl.Acad.Sci.U.S.A 88, 10143-10147


91. World Health Organization (1958) Classification of atherosclerotic lesions; report of a study group. World Health Organ Tech.Rep.Ser. 57, 1-20


92. Wittrup, H. H., Andersen, R. V., Tybjaerg-Hansen, A., Jensen, G. B., Nordestgaard, B. G. (2006) Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross- sectional, prospective, and case-control studies from the Copenhagen City Heart Study. J.Clin.Endocrinol.Metab 91, 1438-1445